MRTX +9.6% (receives FDA accelerated approval of KRAZATI) MRNA +7.8% (Moderna and Merck (MRK) announce investigational cancer vaccine mRNA-4157/V940 has met primary efficacy endpoint) NFE +6.2% (provides update to dividend policy plan to return significant capital to shareholders) NRIX +4.9% (presents positive results from Novel BTK Degrader) KOPN +3.6% (joint tech solution with OPTAC-X and RealWear) NYMT +3.1% (names new President) PGEN +3.1% (Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T) MASI +3% (hosts Investor Day to detail next phase of its growth trajectory at 7:30 am PT (10:30 am ET)) EVGO +2.6% (EVgo Inc. and Lyft (LYFT) launch new partnership to accelerate rideshare electrification nationwide) BA +2.2% (United (UAL) finalized its order to purchase 100 firm Boeing 787 aircraft scheduled to be delivered starting with eight aircraft in 2024) HUT +2% (replaces CFO) NYT +1.5% (CFO to retire next year) SSRM +1.3% (positive exploration results) TNDM +1.1% (to acquire Insulin Patch Pump Developer AMF Medical) DEN +1% (announce agreement for CO2 sequestration site with Weyerhaeuser) Analyst comments:
PHR +2.5% (upgraded to Buy from Neutral at Citigroup) ANGI +1.9% (initiated with a Buy at Citigroup) TTD +1.5% (initiated with a Buy at Citigroup) EQIX +1.4% (upgraded to Outperform from Market Perform at Cowen) W +1.3% (initiated with a Buy at Citigroup) ETSY +0.9% (initiated with a Buy at Citigroup)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.